CN108578698A - Purposes of the Prussian blue-Manganese Ferrite composite nano materials as magnetic heat/photo-thermal combination therapy agent - Google Patents
Purposes of the Prussian blue-Manganese Ferrite composite nano materials as magnetic heat/photo-thermal combination therapy agent Download PDFInfo
- Publication number
- CN108578698A CN108578698A CN201810482385.8A CN201810482385A CN108578698A CN 108578698 A CN108578698 A CN 108578698A CN 201810482385 A CN201810482385 A CN 201810482385A CN 108578698 A CN108578698 A CN 108578698A
- Authority
- CN
- China
- Prior art keywords
- agent
- prussian blue
- photothermal
- purposes
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002131 composite material Substances 0.000 title claims abstract description 29
- 229910052748 manganese Inorganic materials 0.000 title claims abstract description 19
- 239000011572 manganese Substances 0.000 title claims abstract description 19
- 239000002086 nanomaterial Substances 0.000 title claims abstract description 18
- 229910000859 α-Fe Inorganic materials 0.000 title claims abstract description 18
- 239000003795 chemical substances by application Substances 0.000 title claims description 16
- 238000002648 combination therapy Methods 0.000 title claims description 5
- 239000000463 material Substances 0.000 claims abstract description 147
- 239000003814 drug Substances 0.000 claims abstract description 4
- 229940124597 therapeutic agent Drugs 0.000 claims abstract description 4
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 claims description 28
- 229960003351 prussian blue Drugs 0.000 claims description 28
- 239000013225 prussian blue Substances 0.000 claims description 28
- 229910017163 MnFe2O4 Inorganic materials 0.000 claims description 15
- 238000007626 photothermal therapy Methods 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 7
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 238000000554 physical therapy Methods 0.000 claims 8
- 238000002955 isolation Methods 0.000 claims 2
- 238000013007 heat curing Methods 0.000 claims 1
- 230000010354 integration Effects 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 239000002114 nanocomposite Substances 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 35
- 230000000694 effects Effects 0.000 description 29
- 239000000243 solution Substances 0.000 description 18
- 241000699670 Mus sp. Species 0.000 description 17
- 230000008859 change Effects 0.000 description 17
- 238000002474 experimental method Methods 0.000 description 16
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- 201000011510 cancer Diseases 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 11
- 238000001931 thermography Methods 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 7
- 230000004083 survival effect Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 239000000872 buffer Substances 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 229910021642 ultra pure water Inorganic materials 0.000 description 5
- 239000012498 ultrapure water Substances 0.000 description 5
- 206010020843 Hyperthermia Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 230000006907 apoptotic process Effects 0.000 description 4
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 230000036031 hyperthermia Effects 0.000 description 4
- 238000007885 magnetic separation Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 229910001868 water Inorganic materials 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000000684 flow cytometry Methods 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 230000001640 apoptogenic effect Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 238000011056 performance test Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 210000003815 abdominal wall Anatomy 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229940044631 ferric chloride hexahydrate Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000003601 intercostal effect Effects 0.000 description 1
- NQXWGWZJXJUMQB-UHFFFAOYSA-K iron trichloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].Cl[Fe+]Cl NQXWGWZJXJUMQB-UHFFFAOYSA-K 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- CNFDGXZLMLFIJV-UHFFFAOYSA-L manganese(II) chloride tetrahydrate Chemical compound O.O.O.O.[Cl-].[Cl-].[Mn+2] CNFDGXZLMLFIJV-UHFFFAOYSA-L 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 239000012221 photothermal agent Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nanotechnology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明公开了普鲁士蓝‑铁酸锰复合纳米材料作为磁热/光热联合治疗剂的用途。其中,所述的普鲁士蓝‑铁酸锰复合纳米材料为PB‑MnFe2O4纳米复合材料。
The invention discloses the use of a Prussian blue-manganese ferrite composite nanomaterial as a magnetothermal/photothermal combined therapeutic agent. Wherein, the Prussian blue-manganese ferrite composite nanomaterial is PB-MnFe 2 O 4 nanocomposite material.
Description
技术领域technical field
本发明涉及新材料领域,尤其涉及磁热/光热联合治疗剂。The invention relates to the field of new materials, in particular to a magnetothermal/photothermal combined therapeutic agent.
背景技术Background technique
随着目前环境污染、食品安全等社会问题的日益加重,癌症的发病率持续升高,癌症正成为当前威胁人类健康的主要致死疾病之一,全球每年死于癌症的人数约占到总人数的12.5%,人数约900万,仅在2010年,癌症就导致近57万人死亡,并且更加严重的是,患癌人群日益年轻化。癌症现状之所以如此严重,是由其本身的性质决定的。癌症(cancer)也称恶性肿瘤,和它相对的是良性肿瘤,它是由于机体细胞失去正常调控,过度增殖而引起的疾病。过度增殖的细胞俗称癌细胞,癌细胞易侵犯周围组织,易转移、易繁殖、易扩散。With the aggravation of social problems such as environmental pollution and food safety, the incidence of cancer continues to rise, and cancer is becoming one of the major lethal diseases that threaten human health. 12.5%, the number is about 9 million. In 2010 alone, cancer caused nearly 570,000 deaths, and what is more serious is that the cancer population is getting younger and younger. The reason why the status quo of cancer is so serious is determined by its own nature. Cancer is also called malignant tumor, and its opposite is benign tumor, which is a disease caused by the loss of normal regulation and excessive proliferation of body cells. Excessively proliferating cells are commonly called cancer cells. Cancer cells are easy to invade surrounding tissues, transfer, multiply, and spread.
发明内容Contents of the invention
本发明目的之一,在于提供一种普鲁士蓝(PB)-铁酸锰复合纳米材料作为磁热治疗剂的用途,One of the purposes of the present invention is to provide a Prussian blue (PB)-manganese ferrite composite nanomaterial as a magnetothermal therapeutic agent,
本发明的另一目的,在于提供普鲁士蓝-铁酸锰复合纳米材料作为光热治疗剂的用途。Another object of the present invention is to provide the use of the Prussian blue-manganese ferrite composite nanomaterial as a photothermal therapy agent.
本发明的再一目的,在于提供普鲁士蓝-铁酸锰复合纳米材料作为磁热、光热联合治疗剂的用途。Another object of the present invention is to provide the use of the Prussian blue-manganese ferrite composite nanomaterial as a combination therapy of magneto-thermal and photothermal.
本发明所述的普鲁士蓝-铁酸锰复合纳米材料中,PB和MnFe2O4质量比可以为1:1-5。In the Prussian blue-manganese ferrite composite nanomaterial of the present invention, the mass ratio of PB and MnFe 2 O 4 can be 1:1-5.
作为优选,本发明所述的普鲁士蓝-铁酸锰复合纳米材料,PB和MnFe2O4质量比为1:2-3。Preferably, in the Prussian blue-manganese ferrite composite nanomaterial of the present invention, the mass ratio of PB and MnFe 2 O 4 is 1:2-3.
本发明所述的普鲁士蓝-铁酸锰复合纳米材料制备方法包括:取PB及MnFe2O4样品,按照质量浓度1:1-5的比例混合,然后调节溶液pH值为1-4,搅拌过夜后,反复磁性分离、清洗直到溶液澄清为止。The preparation method of the Prussian blue-manganese ferrite composite nanomaterial of the present invention comprises: taking PB and MnFe 2 O 4 samples, mixing according to the ratio of mass concentration 1:1-5, then adjusting the pH value of the solution to 1-4, stirring After overnight, magnetic separation and washing were repeated until the solution was clear.
作为优选,本发明所述的普鲁士蓝-铁酸锰复合纳米材料制备方法包括:取PB及MnFe2O4样品,按照质量浓度1:2-3的比例混合,然后调节溶液pH值为1.5-2.5,搅拌过夜后,反复磁性分离、清洗直到溶液澄清为止。As a preference, the preparation method of the Prussian blue-manganese ferrite composite nanomaterial in the present invention comprises: taking PB and MnFe 2 O 4 samples, mixing according to the ratio of mass concentration 1:2-3, and then adjusting the pH value of the solution to 1.5- 2.5. After stirring overnight, repeat magnetic separation and washing until the solution is clear.
本发明选择PB纳米粒子作为基底,外面粘附一层铁酸锰纳米粒子,但不完全包裹PB,调控两者的结合比例,形成普鲁士蓝-铁酸锰复合纳米材料。并且通过实验发现,复合之后能够起到“1+1>2”的效果,即这种复合材料既有普鲁士蓝的光热效果,又能够表现出铁酸锰的磁热疗功能,是一种能实现磁热、光热联合治疗的复合纳米材料,并且当均为热疗的磁热及光热同时使用时可以进一步提高热疗的效果,升温更快,所需时间更少,效果更明显。因此,这种普鲁士蓝-铁酸锰复合纳米材料能够用于治疗领域。In the present invention, PB nanoparticles are selected as the substrate, and a layer of manganese ferrite nanoparticles is adhered to the outside, but the PB is not completely wrapped, and the combination ratio of the two is regulated to form a Prussian blue-manganese ferrite composite nanomaterial. And through experiments, it is found that after compounding, it can achieve the effect of "1+1>2", that is, this composite material not only has the photothermal effect of Prussian blue, but also can show the magnetic hyperthermia function of manganese ferrite. Composite nanomaterials that can realize the combination therapy of magneto-thermal and photothermal, and when the magnetic-thermal and photothermal are both used together, the effect of thermal therapy can be further improved, the temperature rises faster, the time required is less, and the effect is more obvious . Therefore, this Prussian blue-manganese ferrite composite nanomaterial can be used in the therapeutic field.
附图说明Description of drawings
下面结合附图和实施例对本发明作进一步说明。The present invention will be further described below in conjunction with drawings and embodiments.
图1:材料的光热曲线A)不同浓度的复合材料的光热曲线;B)同一浓度(100μg/ml)不同功率密度的材料的曲线;C)同一浓度(100μg/ml)不同材料的光热曲线;D)材料的循环光热曲线:E)不同浓度的材料的红外热成像图片;Figure 1: Photothermal curves of materials A) Photothermal curves of composite materials with different concentrations; B) Curves of materials with different power densities at the same concentration (100 μg/ml); C) Photothermal curves of different materials with the same concentration (100 μg/ml) Thermal curve; D) cyclic photothermal curve of the material: E) infrared thermal imaging pictures of materials with different concentrations;
图2,材料的磁热升温曲线A)不同浓度的材料;B)不同电流大小;C)同浓度不同的材料;D)不同浓度材料的红外热成像图片;E)材料的SAR值以及对应3分钟时的温度;Figure 2, the magnetocaloric heating curve of materials A) Materials with different concentrations; B) Different currents; C) Materials with different concentrations; D) Infrared thermal imaging pictures of materials with different concentrations; E) SAR values of materials and corresponding 3 temperature in minutes;
图3,细胞的光热实验A)复合材料的MTT图;B)细胞的荧光染色图,b1-b4)依次为不加材料不光照、加材料不光照、不加材料加光照及加材料加光照;Figure 3, photothermal experiment of cells A) MTT diagram of composite material; B) Fluorescent staining diagram of cells, b1-b4) in turn without adding materials and no light, adding materials and no light, adding materials and adding light, and adding materials and adding illumination;
图4,A)细胞的磁热MTT图;B)细胞的磁热荧光染色图,b1-b4)依次为无材料无磁热、有材料无磁热、无材料有磁热、有材料有磁热;Figure 4, A) Magnetic-caloric MTT map of cells; B) Magnetic-caloric fluorescent staining of cells, b1-b4) are sequentially without material without magnetic heat, with material without magnetic heat, without material with magnetic heat, with material and magnetic hot;
图5为细胞的光热流式数据图A)阴性对照组;B)阳性对照组;C-E)材料组,材料的浓度依次为50、100、200mg/ml;Figure 5 is the photothermal flow data diagram of cells A) Negative control group; B) Positive control group; C-E) Material group, the concentration of the material is 50, 100, 200mg/ml in turn;
图6材料在不同情况下的光热磁热升温曲线;A为磁热,500KHz,30A;B)为光热1W/cm2;C)为磁热(500KHz,30A)及光热(1W/cm2)联合升温曲线;A-C的浓度范围为10-100μg/mlD)为样品浓度为200μg/ml时,磁热(500KHz,20A)、光热(1W/cm2)及磁热光热联合升温的曲线;Figure 6 is the photothermal-magnetic-thermal heating curve of materials under different conditions; A is magnetothermal, 500KHz, 30A; B) is photothermal 1W/cm 2 ; C) is magnetothermal (500KHz, 30A) and photothermal (1W/cm2) cm 2 ) combined temperature rise curve; the concentration range of AC is 10-100μg/mlD) is when the sample concentration is 200μg/ml, magneto-thermal (500KHz, 20A), photothermal (1W/cm 2 ) and magneto-thermal-photothermal combined temperature rise the curve;
图7老鼠的光热/磁热联合治疗实验:A)老鼠的红外热成像图;B)肿瘤的升温曲线图;C)老鼠的质量变化曲线;D)肿瘤的体积变化曲线;E)治疗前后老鼠的照片;F)肿瘤的H&E染色切片。Figure 7: Photothermal/Magnetothermal Combined Therapy Experiment of Mice: A) Infrared Thermography of Mice; B) Heating Curve of Tumor; C) Mass Change Curve of Mice; D) Volume Change Curve of Tumor; E) Before and After Treatment Photographs of mice; F) H&E-stained sections of tumors.
图8为病理结果图,12天后小鼠各个脏器的H&E染色切片。Fig. 8 is a picture of the pathological results, H&E stained sections of various organs of the mouse after 12 days.
具体实施方式Detailed ways
1、PB的制备1. Preparation of PB
为现有技术,其合成方法参考相关现有文献,简要如下:取1.5g的PVP(K30)溶入到20mL的水中,然后超声搅拌,直至完全溶解,然后滴加HCl(6M/L)至pH值为3,然后再加入45mg的K3[Fe(CN)6],然后搅拌至完全溶解,然后再加0.192g的柠檬酸,超声至完全溶解。再将其倒入反应釜内衬中,再移入烘箱中,80℃,2h,再室温冷却后清洗。加丙酮,二者按照1:1的比例混合后,高速离心,转速12000rpm/min,12min,然后再用无水乙醇离心,最后再用超纯水离心,然后再将样品60℃真空干燥12h后保存。It is a prior art, and its synthesis method refers to relevant existing documents, which are briefly as follows: get 1.5g of PVP (K30) and dissolve it in 20mL of water, then ultrasonically stir until it is completely dissolved, then add dropwise HCl (6M/L) to The pH value was 3, and then 45mg of K3[Fe(CN) 6 ] was added, and then stirred until completely dissolved, and then 0.192g of citric acid was added, and ultrasonicated until completely dissolved. Then pour it into the lining of the reaction kettle, then move it into the oven, 80°C, 2h, and then clean it after cooling at room temperature. Add acetone, mix the two according to the ratio of 1:1, centrifuge at a high speed at a speed of 12000rpm/min for 12min, then centrifuge with absolute ethanol, and finally centrifuge with ultrapure water, and then vacuum dry the sample at 60°C for 12h save.
2 MnFe2O4的制备2 Preparation of MnFe 2 O 4
为现有技术,MnFe2O4的合成方法参考现有文献,简要如下:取0.01mM的四水合氯化锰倒入50mL的烧杯中,后加入25ml超纯水中,超声震荡使其完全溶解,定为溶液A,然后取0.02mM的六水合氯化铁倒入50mL的烧杯中,后加入25mL超纯水中,超声震荡使其完全溶解,定为溶液B。然后将二者导入100mL的三口烧瓶中,80℃机械搅拌30min,转速600rpm/min,然后加入0.08mM的氢氧化钠,继续搅拌30min,然后再加入0.05g的聚乙烯亚胺,继续搅拌30min后室温冷却。然后磁铁分离,用超纯水清洗,直到溶液澄清为止。最后60℃真空干燥12h后保存。As the prior art, the synthesis method of MnFe2O4 refers to the existing literature, and the brief is as follows: take 0.01mM manganese chloride tetrahydrate and pour it into a 50mL beaker, then add 25ml of ultrapure water, and ultrasonically shake it to dissolve it completely , determined as solution A, then poured 0.02mM ferric chloride hexahydrate into a 50mL beaker, then added 25mL ultrapure water, and ultrasonically oscillated to dissolve it completely, determined as solution B. Then introduce the two into a 100mL three-necked flask, stir mechanically at 80°C for 30min, and rotate at 600rpm/min, then add 0.08mM sodium hydroxide, continue stirring for 30min, then add 0.05g of polyethyleneimine, and continue stirring for 30min Cool at room temperature. Then the magnet separates and washes with ultrapure water until the solution is clear. Finally, it was dried under vacuum at 60°C for 12 hours and then stored.
3 PB/MnFe2O4的制备3 Preparation of PB/MnFe 2 O 4
取上述合成的PB及MnFe2O4样品,按照质量浓度1:2.3的比例混合,然后滴加6M/L的盐酸,使溶液pH值为2,然后机械搅拌过夜,转速300rpm/min,溶液呈墨绿色,然后再磁铁分离,用超纯水清洗,反复磁性分离清洗直到溶液澄清为止。最后60℃真空干燥12h后保存。Take the PB and MnFe 2 O 4 samples synthesized above, mix them according to the ratio of mass concentration 1:2.3, then add 6M/L hydrochloric acid dropwise to make the pH value of the solution 2, then mechanically stir overnight at a speed of 300rpm/min, the solution is Dark green, then magnetic separation, cleaning with ultrapure water, repeated magnetic separation and cleaning until the solution is clear. Finally, it was dried under vacuum at 60°C for 12 hours and then stored.
4、细胞的光热及磁热实验4. Cell photothermal and magnetothermal experiments
为了从细胞水平验证验证材料的光热及磁热性能,步骤如下:1)选取对数生长期细胞,用胰蛋白酶消化,PBS缓冲液清洗2次,再以5×105mL-1的浓度接种于12孔板内,分成两组,一组用MTT法检验,另一组进行Calcein AM/PI染色处理,每孔体积为1.5mL,然后移入恒温培养箱中孵育24h;2),再移除原培养液,PBS缓冲液清洗2次,然后再加入含不同材料浓度(400μg/mL、200μg/mL、100μg/mL、50μg/mL、25μg/mL、不加材料组)的培养液,再移入恒温培养箱中孵育4h;然后分别进行光热辐照实验、磁热实验以及光热磁热联合治疗实验,然后再次移入恒温培养箱中孵育,MTT组24h,染色组4h;然后MTT组加入20ml MTT,再继续培养4h,再去上清液,用DMSO溶解沉淀,然后再用分光光度计测定570nm处的吸光度,以不加材料组作为对照组,计算细胞成活率。另一组孵育4h后,去除上清液5mL的Calcein AM和PI,然后再避光的条件下,放入水平摇床上,20r/min,10min,再孵育30min。然后再取出,去除上清液,PBS缓冲液轻轻清洗2次,再每个孔加入100μL的培养液,最后拿到荧光显微镜下观察,拍照。In order to verify the photothermal and magnetothermal properties of the material from the cellular level, the steps are as follows: 1) Select the cells in the logarithmic growth phase, digest with trypsin, wash twice with PBS buffer, and then use the concentration of 5×10 5 mL-1 Inoculated in 12-well plates, divided into two groups, one group was tested by MTT method, the other group was stained with Calcein AM/PI, the volume of each hole was 1.5mL, and then moved into a constant temperature incubator for incubation for 24h; 2), and then transferred In addition to the original culture solution, PBS buffer was washed twice, and then the culture solution containing different material concentrations (400 μg/mL, 200 μg/mL, 100 μg/mL, 50 μg/mL, 25 μg/mL, no material group) was added, and then Move them into a constant temperature incubator and incubate for 4 hours; then carry out photothermal irradiation experiment, magnetothermal experiment and photothermal magnetothermal combined treatment experiment respectively, and then move them into a constant temperature incubator for incubation again, MTT group for 24 hours, dyeing group for 4 hours; then MTT group added 20ml of MTT, continue to culture for 4h, then remove the supernatant, dissolve the precipitate with DMSO, and then measure the absorbance at 570nm with a spectrophotometer, and use the group without material as the control group to calculate the cell survival rate. After the other group was incubated for 4 hours, 5 mL of Calcein AM and PI in the supernatant were removed, and then placed on a horizontal shaker at 20 r/min for 10 minutes in the dark, and incubated for another 30 minutes. Then take it out again, remove the supernatant, wash gently twice with PBS buffer, add 100 μL of culture solution to each well, and finally observe and take pictures under a fluorescent microscope.
5、细胞流式实验5. Cell flow experiments
处理细胞,收集处理的细胞,用70%冷乙醇固定过夜,次日用PBS缓冲液清晰两次,室温下,用Calcein AM和PI染色液避光染色30min,最后用流式细胞仪检测细胞凋亡率,其中不加材料组为空白对照组。Treat the cells, collect the treated cells, fix them overnight with 70% cold ethanol, clear them twice with PBS buffer the next day, and stain them with Calcein AM and PI staining solution in the dark for 30 minutes at room temperature, and finally detect cell apoptosis by flow cytometry Mortality rate, and the group without material was the blank control group.
6、肿瘤的种植6. Tumor implantation
将4T1细胞株进行传代扩增,制备成1×108mL-1的细胞悬浮液。然后将老鼠分组,分为8组,每组3只,分别是单纯PBS组、PBS+MFH组、PBS+PTT组、PBS+MFH+PTT组、材料组、材料+MFH组、材料+PTT组以及材料+MFH+PTT组。然后分别在老鼠的胸壁5-6肋间和侧腹壁皮下接种相应浓度的细胞悬浮液,然后每天观察小鼠生活饮食以及接种部位瘤块的生长状况,如瘤体出现时间、瘤体体积(V=ab2/2,a为瘤体的长径,b为短径)、老鼠质量等,并绘制曲线。实验完成后,取瘤体组织进行HE染色进行病理观察。The 4T1 cell line was subcultured and expanded to prepare a cell suspension of 1×10 8 mL-1. Then the mice were divided into 8 groups, 3 in each group, which were pure PBS group, PBS+MFH group, PBS+PTT group, PBS+MFH+PTT group, material group, material+MFH group, material+PTT group And the material+MFH+PTT group. Then respectively in the chest wall 5-6 intercostal space of mice and the cell suspension of side abdominal wall subcutaneous inoculation corresponding concentration, then observe the growth situation of mouse living diet and inoculation site tumor piece every day, as tumor body appearance time, tumor body volume (V =ab2/2, a is the long diameter of the tumor, b is the short diameter), the weight of the mouse, etc., and draw the curve. After the experiment was completed, tumor tissues were taken for HE staining for pathological observation.
7、动物治疗7. Animal treatment
为了在动物水平验证材料的治疗功能,主要是指材料的磁热性能、光热性能以及磁热光热叠加后的性能,选择Blab/C老鼠作为实验对象。首先单独进行老鼠的磁热实验以及光热实验,首先将老鼠麻醉后,原位注射50μl,200μg/ml的材料,然后将老鼠置于磁加热设备及激光下,用红外热成像仪记录老鼠肿瘤区域的温度的变化。然后进行磁热光热叠加实验,将激光器和磁加热设备联合搭配起来,再老鼠麻醉,原位注射材料,再将老鼠放入搭建的仪器中,用红外热成像仪记录老鼠肿瘤区间的温度。按照先前老鼠的分组情况(单纯PBS组、材料+MFH组、材料+PTT组以及材料+MFH+PTT组),依次检测。每天拍照并检测老鼠肿瘤以及体重的变化,再根据老鼠的肿瘤消失情况停止治疗。In order to verify the therapeutic function of the material at the animal level, mainly referring to the magnetocaloric properties, photothermal properties and the superimposed properties of magnetothermal and photothermal properties of the material, Blab/C mice were selected as the experimental subjects. Firstly, the magnetothermal experiment and photothermal experiment of the mouse were carried out separately. After the mouse was anesthetized, 50μl, 200μg/ml material was injected in situ, and then the mouse was placed under the magnetic heating equipment and laser, and the tumor of the mouse was recorded with an infrared thermal imager Changes in the temperature of the area. Then, the magnetothermal photothermal superposition experiment was carried out, the laser and the magnetic heating equipment were combined and matched, the mouse was anesthetized, the material was injected in situ, and then the mouse was put into the built instrument, and the temperature of the tumor area of the mouse was recorded with an infrared thermal imager. According to the previous grouping of the mice (pure PBS group, material+MFH group, material+PTT group and material+MFH+PTT group), the detection was performed sequentially. Take pictures every day and detect the changes in the tumors and body weight of the mice, and then stop the treatment according to the disappearance of the tumors in the mice.
8、HE染色8. HE staining
老鼠治疗完成后,对老鼠解剖,分离内脏,包括心、肝、脾、肺、肾及肿瘤,做组织切片进行病理学观察。染色是将染料配制成溶液,将组织切片浸入染色剂内,经过一定时间,使组织和细胞的成分被染上不同的颜色,产生不同的折射率,便于在光学显微镜下进行观察。染色采用苏木素伊红染色法(HE染色)。After the mice were treated, the mice were dissected, and the viscera were separated, including the heart, liver, spleen, lung, kidney and tumor, and tissue sections were made for pathological observation. Staining is to prepare dyes into solutions, immerse tissue sections in the staining agent, and after a certain period of time, the components of tissues and cells will be dyed with different colors, resulting in different refractive indices, which are convenient for observation under an optical microscope. Hematoxylin and eosin staining (HE staining) was used for staining.
实施例1复合材料的毒性检测The toxicity detection of embodiment 1 composite material
将灭菌的PB/MnFe2O4材料进行细胞毒性测试,通过检测细胞在不同浓度的材料(400μg/mL、200μg/mL、100μg/mL、50μg/mL、25μg/mL、不加材料组)共培养中的存活情况(材料使用浓度是由10μL材料+90μL的培养基定量混匀制备而成),MTT(3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide)法,这里选取的细胞对象为HeLa细胞和4T1细胞,具体实验操作如下:The sterilized PB/MnFe2O4 material was tested for cytotoxicity by detecting the co-culture of cells in different concentrations of materials (400μg/mL, 200μg/mL, 100μg/mL, 50μg/mL, 25μg/mL, no material group) Survival conditions of (material concentration is prepared by quantitatively mixing 10μL material + 90μL medium), MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H- tetrazolium bromide) method, the cell objects selected here are HeLa cells and 4T1 cells, and the specific experimental operations are as follows:
细胞计数:将处于对数生长期细胞置于超净工作台中,移除培养皿中的原培养基(小心处理,避免细胞由于吸力过大而被吸走),再向其加入2mL PBS缓冲溶液清洗2次,再用移液枪移取1mL的胰蛋白酶(25%)进行细胞消化,2min后,加入1mL培养基吹打终止消化(此时显微镜下可以看到细胞漂浮,未贴壁),然后用1.5mL离心管收集,后离心处理,转速3000r/min,时间5min,离心后,移除上清液,加入2mL培养基,然后用移液枪轻轻吹打细胞(30~50次)。取10μL的细胞悬液,取至血球计数板中进行计数,通过计算四个计数区的平均数,从而确定总的细胞悬液的细胞量。Cell counting: Place the cells in the logarithmic growth phase in an ultra-clean workbench, remove the original medium in the culture dish (handle carefully to avoid the cells being sucked away due to excessive suction), and then add 2mL of PBS buffer solution to it Wash twice, then use a pipette to pipette 1 mL of trypsin (25%) to digest the cells. After 2 minutes, add 1 mL of medium and pipette to stop the digestion (at this time, the cells can be seen floating and not attached to the wall under the microscope), and then Use a 1.5mL centrifuge tube to collect, then centrifuge at a speed of 3000r/min for 5min. After centrifugation, remove the supernatant, add 2mL of medium, and gently blow the cells with a pipette gun (30-50 times). Take 10 μL of the cell suspension, take it to a hemocytometer for counting, and calculate the average number of the four counting areas to determine the cell amount of the total cell suspension.
接种:然后将目标为104个细胞接种至96孔板中,加入一定量含血清的培养基(使得细胞每孔培养基的总量为100μL),然后放入恒温培养箱中,孵育24h,使细胞能够充分的贴壁生长。Inoculation: Then inoculate 104 target cells into a 96-well plate, add a certain amount of serum-containing medium (so that the total amount of medium in each well of the cells is 100 μL), and then put it in a constant temperature incubator and incubate for 24 hours, so that Cells can grow adequately on the wall.
加材料:移除培养基,加入100μL的PBS缓冲液,清洗2次,然后分别加入目标浓度的材料:400μg/mL、200μg/mL、100μg/mL、50μg/mL、25μg/mL、不加材料组。每组设定5个重复组,在37℃的恒温培养箱中共培养24h。达到目标时间后,移除培养基,并用PBS缓冲溶液清洗3次(以便移除多余的残留的材料溶液)。Adding materials: Remove the medium, add 100 μL of PBS buffer, wash twice, and then add materials of target concentration: 400 μg/mL, 200 μg/mL, 100 μg/mL, 50 μg/mL, 25 μg/mL, no material Group. Each group set up 5 repeated groups and co-cultured for 24 hours in a constant temperature incubator at 37°C. After reaching the target time, the culture medium was removed and washed 3 times with PBS buffer solution (in order to remove excess residual material solution).
MTT检测:再每孔加入20μL 5mg/mL的MTT溶液和80μL的无血培养基,然后再放入37℃恒温培养箱中避光孵育4h。4h后,小心移除培养液(避免细胞被吸出从而影响实验结果),然后每孔再加入150μL DMSO,并在避光的条件下,将96孔板放入水平摇床20r/min,10min,然后放置于酶标仪中进行紫外检测,最终获得每孔的OD值,将OD值整理绘制,得到HeLa和4T1细胞的活性数据图。MTT detection: Add 20 μL of 5 mg/mL MTT solution and 80 μL of blood-free medium to each well, and then place them in a constant temperature incubator at 37°C and incubate for 4 hours in the dark. After 4 hours, carefully remove the culture medium (avoid the cells being sucked out and affect the experimental results), then add 150 μL DMSO to each well, and put the 96-well plate on a horizontal shaker at 20 r/min for 10 min under the condition of avoiding light. Then place it in a microplate reader for ultraviolet detection, and finally obtain the OD value of each well, and arrange and draw the OD value to obtain the activity data graph of HeLa and 4T1 cells.
见图8,根据上述结果,得到这种磁性普鲁士蓝材料具有较好的生物相容性。As shown in Fig. 8, according to the above results, the magnetic Prussian blue material has good biocompatibility.
实施例2材料的光热性能The photothermal performance of embodiment 2 material
将得到的样品溶液,取一定浓度的样品于紫外皿中,然后将其置于激光器下辐照10min,同时用红外热成像仪采集图片,记录材料温度随时间的变化情况。具体步骤如下:Take the obtained sample solution, take a certain concentration of the sample in the ultraviolet dish, and then put it under the laser irradiation for 10 minutes, and use the infrared thermal imager to collect pictures at the same time, and record the change of the temperature of the material with time. Specific steps are as follows:
根据激光功率密度[12]公式:According to the laser power density [12] formula:
η=P/π·R2 (1)η=P/π·R 2 (1)
η:激光功率密度,单位W/cm2;η: laser power density, unit W/cm 2 ;
P:激光功率,单位W;P: laser power, unit W;
R:激光照射在物体上光斑的半径,单位cm。R: The radius of the light spot on the object irradiated by the laser, in cm.
选定激光功率的大小,然后固定激光器的探头,激光照射到地面上后出现一个光斑,然后拿直尺量取光斑的直径以及探头到地面的距离,按照激光功率密度调节距离,然后将紫外比色皿放在光斑处,开始记录材料的温度变化,绘制时间温度曲线,同时用红外热成像仪采集温度变化图片。从4个角度出发,分别是同一浓度的不同的材料,H2O、PB、MnFe2O4及PB/MnFe2O4;同一激光功率密度下不同材料浓度的复合材料,10μg/mL、20μg/mL、50μg/mL及100μg/mL;不同激光功率密度下的同一浓度的复合材料,0、0.5W/cm2、1W/cm2、2W/cm2;光热循环实验,主要验证复合材料的光热稳定性,材料受激光照射10min后,关掉激光,记录材料温度的变化,降到室温后再打开激光,照射10min,然后再关掉激光,依次类推,重复3次。Select the laser power, then fix the laser probe, a light spot will appear after the laser is irradiated on the ground, then take a ruler to measure the diameter of the light spot and the distance from the probe to the ground, adjust the distance according to the laser power density, and then adjust the UV ratio The color dish is placed at the light spot, and the temperature change of the material is recorded, and the time-temperature curve is drawn. At the same time, the infrared thermal imager is used to collect pictures of the temperature change. Starting from 4 angles, they are different materials with the same concentration, H2O, PB, MnFe2O4 and PB/MnFe2O4; composite materials with different material concentrations under the same laser power density, 10μg/mL, 20μg/mL, 50μg/mL and 100μg /mL; composite materials with the same concentration under different laser power densities, 0, 0.5W/cm 2 , 1W/cm 2 , 2W/cm 2 ; photothermal cycle experiments mainly verify the photothermal stability of composite materials. After 10 minutes of laser irradiation, turn off the laser, record the temperature change of the material, turn on the laser after cooling down to room temperature, irradiate for 10 minutes, then turn off the laser, and so on, repeat 3 times.
材料的光热性能测试Photothermal performance test of materials
图1为材料的光热曲线A)不同浓度的复合材料的光热曲线;B)同一浓度(100μg/ml)不同功率密度的材料的曲线;C)同一浓度(100μg/ml)不同材料的光热曲线;D)材料的循环光热曲线:E)不同浓度的材料的红外热成像图片。Figure 1 is the photothermal curve of the material A) Photothermal curves of composite materials with different concentrations; B) Curves of materials with the same concentration (100 μg/ml) and different power densities; C) Photothermal curves of different materials with the same concentration (100 μg/ml) Thermal curve; D) Cyclic photothermal curve of the material: E) Infrared thermal imaging pictures of materials with different concentrations.
基于上面紫外光谱测试分析发现材料在近红外区具有很强的吸收峰,对材料的光热性能进行测试。首先验证复合材料是否具有光热性能,选取了4个材料浓度,如图1A,依次为10μg/mL、20μg/mL、50μg/mL和100μg/mL。发现当激光功率密度为2W/cm2时,即使材料浓度很低,10min内材料前后的温度差仍能达到10℃,升温明显,且浓度越高,升温越明显,最高温差能达到近30℃,说明材料有很好的光热性能。Based on the above ultraviolet spectrum test analysis, it is found that the material has a strong absorption peak in the near infrared region, and the photothermal performance of the material is tested. First, to verify whether the composite material has photothermal properties, four material concentrations were selected, as shown in Figure 1A, which were 10 μg/mL, 20 μg/mL, 50 μg/mL and 100 μg/mL. It is found that when the laser power density is 2W/cm2, even if the material concentration is very low, the temperature difference between the front and back of the material can still reach 10°C within 10 minutes, and the temperature rises significantly, and the higher the concentration, the more obvious the temperature rise, and the highest temperature difference can reach nearly 30°C. It shows that the material has good photothermal performance.
条件的影响,如激光功率密度,见图1B,选了4个参数,分别为0W/cm2、0.5W/cm2、1W/cm2、2W/cm2,材料的浓度为100μg/ml。发现功率密度越大,升温越明显,温度依次为0℃、38℃、48℃以及57℃。The influence of conditions, such as laser power density, is shown in Figure 1B. Four parameters were selected, namely 0W/cm2, 0.5W/cm2, 1W/cm2, and 2W/cm2, and the concentration of the material was 100μg/ml. It was found that the higher the power density, the more obvious the temperature rise, and the temperatures were 0°C, 38°C, 48°C, and 57°C.
材料复合的影响,如图1C,选择同一浓度的H2O、PB、MnFe2O4和PB/MnFe2O4材料,激光功率为2W/cm2。发现H2O前后几乎没有温度的变化,MnFe2O4有一定的上升,但不是很明显。而PB和PB/MnFe2O4前后温差变化很大,均有很强的光热性能,但材料复合后温度稍高与单一的PB材料,二者复合后有一定的温度叠加效果。The effect of material recombination, as shown in Figure 1C, select H 2 O, PB, MnFe 2 O 4 and PB/MnFe 2 O 4 materials with the same concentration, and the laser power is 2W/cm2. It is found that there is almost no temperature change before and after H 2 O , and there is a certain increase in MnFe 2 O 4 , but not very obvious. However, the temperature difference between PB and PB/MnFe2O4 varies greatly before and after, and both have strong photothermal properties, but the temperature after the material is compounded is slightly higher than that of a single PB material, and there is a certain temperature superposition effect after the two are compounded.
接下来是材料的光热循环稳定性测试,主要是为了测试材料的光热稳定性,结果如图D所示。每隔10min开关一次激光器,但不停止材料温度的检测,3次循环后发现材料温度10min内均能上升到55℃,表明材料具有良好的光热稳定性。Next is the photothermal cycle stability test of the material, mainly to test the photothermal stability of the material, and the results are shown in Figure D. The laser was turned on and off every 10 minutes, but the detection of the material temperature was not stopped. After 3 cycles, it was found that the material temperature could rise to 55°C within 10 minutes, indicating that the material had good photothermal stability.
图E是材料的红外热成像图片,主要是用红外热成像仪采集材料的温度图片,颜色的明亮深浅直接反应出材料的温度高低,从中可发现材料的光热性能较好。Figure E is the infrared thermal imaging picture of the material. It mainly collects the temperature picture of the material with an infrared thermal imaging camera. The brightness and depth of the color directly reflect the temperature of the material, and it can be found that the photothermal performance of the material is better.
细胞光热实验Cell Photothermal Experiment
参见图3,图3A为材料和材料受激光照射后的MTT图,从中可以看出材料的细胞毒性较小,即使是材料浓度很高时(400μg/mL)时,仍然有超过80%的细胞存活,一般细胞存活率超过75%时,则表明生物毒性小,生物相容性高。而受激光照射后,细胞存活率显著下降,细胞存活率不到40%,这是由于材料受到激光辐射后,温度上升,细胞死亡,从细胞水平表明了材料的光热性能良好。See Figure 3, Figure 3A is the MTT diagram of the material and the material after being irradiated by laser light, from which it can be seen that the cytotoxicity of the material is small, even when the material concentration is very high (400 μg/mL), there are still more than 80% of the cells Survival, generally when the cell survival rate exceeds 75%, it indicates that the biotoxicity is small and the biocompatibility is high. After being irradiated by laser, the cell survival rate decreased significantly, and the cell survival rate was less than 40%. This was because the temperature of the material rose and the cells died after being irradiated by laser, which indicated that the photothermal performance of the material was good from the cell level.
图3B是材料的摄取率,从中可以看出材料能够被细胞摄取,且随着时间的延长,细胞的摄取率越高,能达到25%。Figure 3B is the uptake rate of the material, from which it can be seen that the material can be taken up by the cells, and as time goes on, the uptake rate of the cells is higher, reaching 25%.
图3C-F为细胞受激光照射后通过calcein AM和PI染色后的图片,发现不加材料不加激光的HeLa细胞全部被染成绿色荧光,表明此对照组细胞正常生长,而单纯的材料不引起光热反应,细胞仍为绿色荧光。而当只加激光光照时,细胞没有出现明显的变化,仍全部被染成绿色荧光,表明细胞存活。在没有光热剂的情况下,单纯的808nm激光照射不会产生光热反应,因此不会对细胞产生影响。而在材料和激光同时存在的影响下,在荧光显微镜的观察下,一角出现红色荧光,虽然这一角的范围比激光照射的区域大,但也与照射区域符合。红色区域较大是因为材料具有光热效应,将吸收的热量转化为热量从而杀死细胞,而由于热量的扩散,相邻近的细胞活性也受到影响,故而较大,但就算如此,照射区域外仍有正常细胞。综上所述,这种磁性普鲁士蓝复合材料可通过近红外光热效应高效杀死细胞,因此在癌症的光热治疗中具有重大的意义。Figure 3C-F are pictures of cells stained by calcein AM and PI after being irradiated with laser light. It was found that HeLa cells without materials and laser were all stained with green fluorescence, indicating that the cells in the control group grew normally, while the simple materials did not. The photothermal reaction is caused, and the cells are still green fluorescent. However, when only laser light was applied, the cells did not change significantly, and all of them were still stained with green fluorescence, indicating that the cells were alive. In the absence of photothermal agents, pure 808nm laser irradiation will not produce photothermal reactions, so it will not affect cells. Under the influence of the simultaneous presence of the material and the laser, under the observation of the fluorescence microscope, red fluorescence appears at one corner. Although the range of this corner is larger than the area irradiated by the laser, it also conforms to the irradiated area. The red area is larger because the material has a photothermal effect, which converts the absorbed heat into heat to kill the cells, and due to the diffusion of heat, the activity of adjacent cells is also affected, so it is larger, but even so, outside the irradiation area There are still normal cells. In summary, this magnetic Prussian blue composite can efficiently kill cells through the near-infrared photothermal effect, and thus has great significance in the photothermal therapy of cancer.
接下来进行细胞流式的表征,将处理好后的细胞拿流式细胞仪检测,数据如下所示。Next, perform cell flow cytometry characterization, and take the processed cells for flow cytometry detection, and the data are shown below.
图5为细胞的光热流式数据图A)阴性对照组B)阳性对照组C-E)材料组,材料的浓度依次为50、100、200mg/ml。Figure 5 is the photothermal flow data diagram of cells A) Negative control group B) Positive control group C-E) Material group, the concentration of the material is 50, 100, 200 mg/ml in sequence.
从图中可以看出作为阴性对照组的图A,细胞凋亡较少,大部分细胞处于活细胞状态,而作为阳性对照组,由于加入了20mM的H2O2,所以有超过60%的细胞处于凋亡状态,而图C、D、E为实验组,分别加入了不同浓度MPB NPs材料,在激光的照射下产生热量,进而导致细胞的凋亡,可以看到,随着浓度的增加,活细胞的占比逐渐减少,而凋亡细胞的占比逐渐升高,说明了材料的光热效果好,也表明了这种材料具有优良的光热效果。It can be seen from the figure that in Figure A, which is the negative control group, there is less apoptosis, and most of the cells are in the state of living cells, while as the positive control group, due to the addition of 20mM H2O2, more than 60% of the cells are in the state of apoptosis Figures C, D, and E are the experimental groups, in which different concentrations of MPB NPs materials were added, and heat was generated under laser irradiation, which led to cell apoptosis. It can be seen that with the increase of the concentration, the living cells The proportion of apoptotic cells gradually decreased, while the proportion of apoptotic cells gradually increased, which shows that the material has a good photothermal effect, and also shows that this material has an excellent photothermal effect.
动物治疗animal therapy
接着进行老鼠的热疗实验,如图7所示。其中图7A为治疗中的肿瘤温度实时曲线,从中可以看出除治疗组外(materials+MFH、materials+PTT、materials+MFH+PTT)温度均无明显变化,在36℃上下波动。而治疗组2分钟内变化较明显,其中磁热的达到43℃,光热的达到44℃,而联合治疗的两分钟能够达到55℃,从中可以看出材料在动物水平上具有很好的效果,从图7B中更能直观的看出前后的温度变化。图7C图为老鼠的质量变化,与最初相比,质量几乎保持平衡。图7D为老鼠肿瘤的体积变化曲线,从中可以看出除治疗组外,肿瘤的体积均显著增大,12天之后,约为最初的8倍大小。而磁热为最初的4倍大小,光热的为最初的3倍大小。而磁热联合光热组的肿瘤3天就消失了,直接反映出材料的光热磁热联合治疗效果。而从图7E图的照片效果可直接看出肿瘤的变化情况,从而反映出材料具有光热磁热联合治疗的高效治疗效果。Next, the hyperthermia experiment on mice was carried out, as shown in FIG. 7 . Figure 7A is the real-time curve of tumor temperature during treatment, from which it can be seen that except for the treatment group (materials+MFH, materials+PTT, materials+MFH+PTT) the temperature did not change significantly, fluctuating around 36°C. In the treatment group, the changes were more obvious within 2 minutes, among which the magnetothermal treatment reached 43°C, the photothermal treatment reached 44°C, and the combined treatment could reach 55°C within 2 minutes, from which it can be seen that the material has a good effect on the animal level. , the temperature change before and after can be seen more intuitively from Figure 7B. Figure 7C graphs the change in mass of the mouse, which remains nearly balanced compared to the initial mass. Figure 7D is the volume change curve of the mouse tumors, from which it can be seen that except for the treatment group, the volume of the tumors increased significantly, and after 12 days, it was about 8 times the original size. The magneto-thermal ones are 4 times the original size, and the photothermal ones are 3 times the original size. In contrast, the tumors in the magnetothermal combined with photothermal group disappeared within 3 days, which directly reflects the therapeutic effect of the material. From the effect of the photo in Figure 7E, the changes of the tumor can be seen directly, which reflects that the material has a high therapeutic effect of combined photothermal, magnetic and thermal therapy.
病理分析pathological analysis
图8 12天后小鼠各个脏器以及肿瘤的H&E染色切片,标尺:100μmFigure 8 H&E stained sections of various organs and tumors of mice after 12 days, scale bar: 100 μm
接着利用H&E染色分析各个器官的组织和细胞形态,如图8所示。将实验组与对照组进行前后对比,通过比较可知,八组小鼠的心、肝、脾、肺、肾在组织形态上并没有明显的变化,说明材料具有较好的生物安全性,对小鼠没有明显的毒副作用,且在整个治疗过程中小鼠生理状态良好。而观察肿瘤的组织切片发现有较大的改变,实验组的肿瘤组织中出现了大面积的细胞皱缩,血管损伤和组织坏死的现象,这表明治疗组中肿瘤组织已经失去了生理活性,不再具有生长增值的能力。Then, the tissue and cell morphology of each organ were analyzed by H&E staining, as shown in FIG. 8 . Comparing the experimental group with the control group before and after, it can be seen from the comparison that the heart, liver, spleen, lung, and kidney of the mice in the eight groups have no obvious changes in tissue morphology, indicating that the material has good biological safety and is suitable for small The mice had no obvious toxic and side effects, and the physiological status of the mice was good during the whole treatment process. However, the tissue sections of the tumor showed significant changes. Large areas of cell shrinkage, blood vessel damage and tissue necrosis appeared in the tumor tissue of the experimental group, which indicated that the tumor tissue in the treatment group had lost its physiological activity. Then have the ability to grow and increase value.
实施例3材料的磁热实验The magnetocaloric experiment of embodiment 3 materials
本实施例主要考察材料的磁热性能,在测试的同时用荧光光纤测温计记录材料溶液的温度变化,主要从3个角度出发:1,材料的浓度,200μg/mL、400μg/mL、800μg/mL;2,实验测试条件,如电流、场强、频率等,而这里主要是指磁感应线圈电流的大小,当材料浓度不变时,改变电流大小,5A、10A、20A、30A及40A;3,同一实验条件,同种浓度但不同的材料,H2O、PB、MnFe2O4及PB/MnFe2O4。根据测得的温度绘制时间温度曲线,并且根据曲线计算材料的产热率(Specific Absorption Rate,SAR)[13],也就是单位质量的样品将能量转化为热能的量,产热率越高,磁热性能越好:This example mainly investigates the magneto-caloric properties of the material. During the test, a fluorescent optical fiber thermometer is used to record the temperature change of the material solution, mainly from three angles: 1. The concentration of the material, 200μg/mL, 400μg/mL, 800μg /mL; 2. Experimental test conditions, such as current, field strength, frequency, etc., and here mainly refers to the size of the magnetic induction coil current. When the material concentration is constant, change the current size, 5A, 10A, 20A, 30A and 40A; 3. The same experimental conditions, the same concentration but different materials, H2O, PB, MnFe2O4 and PB/MnFe2O4. Draw the time-temperature curve according to the measured temperature, and calculate the heat production rate (Specific Absorption Rate, SAR) of the material according to the curve [13], which is the amount of energy converted into heat energy per unit mass of the sample. The higher the heat production rate, The better the magnetocaloric performance:
式中:C为材料溶液的比热容,J/g K;In the formula: C is the specific heat capacity of the material solution, J/g K;
ΔT/Δt为温度时间曲线的斜率;ΔT/Δt is the slope of the temperature-time curve;
mFe为单位质量的材料所含的铁元素的含量。m Fe is the content of iron element contained in a unit mass of material.
材料的磁热性能测试Magnetic-caloric performance test of materials
图2材料的磁热升温曲线A)不同浓度的材料;B)不同电流大小;C)同浓度不同的材料;D)不同浓度材料的红外热成像图片;E)材料的SAR值以及对应3分钟时的温度Figure 2 The magnetocaloric heating curve of materials A) Materials with different concentrations; B) Different current sizes; C) Materials with different concentrations at the same concentration; D) Infrared thermal imaging pictures of materials with different concentrations; E) SAR values of materials and corresponding 3 minutes temperature
通过VSM测试,发现材料有较高的磁性,所以接下来主要测试材料的磁热性能。主要从3个角度出发,分别是材料的浓度、实验测试的条件、磁加热的SAR值以及材料复合前后的影响。Through the VSM test, it is found that the material has high magnetic properties, so the next step is to test the magnetocaloric properties of the material. Mainly from three perspectives, namely the concentration of the material, the conditions of the experimental test, the SAR value of the magnetic heating, and the influence of the material before and after compounding.
图2A是探讨材料浓度的影响,在500KHz,12A/H实验条件下,选取了3个浓度,200μg/mL、400μg/mL和800μg/mL。从中发现浓度越高,材料的升温性能越好,也就说明材料的磁热性能越好,即使浓度很低(200μg/mL)时,温度仍能达到42℃。Figure 2A is to explore the influence of material concentration. Under the experimental conditions of 500KHz and 12A/H, three concentrations were selected, 200μg/mL, 400μg/mL and 800μg/mL. It is found that the higher the concentration, the better the temperature rise performance of the material, which means the better the magnetocaloric performance of the material. Even at a very low concentration (200μg/mL), the temperature can still reach 42°C.
接下来是实验条件的影响,如图2B所示。发现电流越大,升温越快,尤其是当实验电流为40A时,3min内电流迅速上升至70℃,非常明显。Next is the effect of experimental conditions, as shown in Fig. 2B. It is found that the larger the current, the faster the temperature rise, especially when the experimental current is 40A, the current rises rapidly to 70°C within 3 minutes, which is very obvious.
图2C是为探讨材料复合对磁热性能是否有影响。发现H2O和PB温度几乎没变化,而MnFe2O4和PB/MnFe2O4升温明显,10min内能均达到42℃以上,能达到治疗的效果。且复合后,材料温度稍稍高于单一的MnFe2O4,主要是因为材料粒径变大了,而磁热性能受材料粒径的影响,在一定范围内,粒径越大,温度越高。Figure 2C is to explore whether material compounding has an effect on the magnetocaloric properties. It was found that the temperature of H2O and PB hardly changed, but the temperature of MnFe2O4 and PB/MnFe2O4 increased significantly, and both could reach above 42°C within 10 minutes, which could achieve the therapeutic effect. And after compounding, the temperature of the material is slightly higher than that of single MnFe2O4, mainly because the particle size of the material becomes larger, and the magnetocaloric properties are affected by the particle size of the material. Within a certain range, the larger the particle size, the higher the temperature.
图2D是材料的红外热成像图片,主要通过红外热成像仪从宏观角度上反应材料温度的变化,温度越高,颜色越亮。发现磁处理前后,材料变化较为明显。Figure 2D is an infrared thermal imaging picture of the material, which mainly reflects the temperature change of the material from a macroscopic perspective through the infrared thermal imaging camera. The higher the temperature, the brighter the color. It is found that before and after the magnetic treatment, the material change is more obvious.
图2E为材料的SAR值,对应的3min的时候,直接反应出材料的磁热性能,SAR越高,磁热性能越好,能达到近1000W/g,相对于一些相关文献报告,数值较高。Figure 2E is the SAR value of the material, corresponding to 3 minutes, it directly reflects the magnetocaloric properties of the material, the higher the SAR, the better the magnetocaloric properties, which can reach nearly 1000W/g, compared with some related literature reports, the value is higher .
细胞的磁热效应Magnetocaloric Effect of Cells
从图4可以看出,磁热效果类似于图3光热的效果,经磁热处理后,细胞的活性下降,生存率下降,说明材料具有磁热效果,将吸收的磁能转化为热能,从而将细胞杀死,并且从荧光染色效果可以看出这一点,材料经磁加热后,细胞的活性降低甚至死亡,因此细胞为染上荧光,在荧光显微镜下只看到少量绿色荧光,大部分呈现出黑色,间接说明了材料的磁热效果,表明这种材料可以用于癌症的磁热治疗。It can be seen from Figure 4 that the magnetocaloric effect is similar to the photothermal effect in Figure 3. After magnetothermic treatment, the activity of cells and the survival rate decreased, indicating that the material has a magnetocaloric effect, which converts the absorbed magnetic energy into heat energy, thereby converting Cells are killed, and this can be seen from the fluorescent staining effect. After the material is magnetically heated, the activity of the cells decreases or even dies. Therefore, the cells are not stained with fluorescence. Black color indirectly illustrates the magnetocaloric effect of the material, indicating that this material can be used for magnetothermic therapy of cancer.
实施例4材料的磁热光热叠加使用Magnetothermal-optical-thermal superimposed use of the material of embodiment 4
根据上述的材料的光热及磁热结果,选取200mg/ml的浓度进行检测(此温度下材料均具有升温效果,尤其是光热),搭建磁热光热平台,然后再在光热和磁热的实验条件下测量相同的时间,同时用红外热成像以拍照记录温度的变化,然后绘制时间温度曲线。According to the photothermal and magnetothermal results of the above materials, a concentration of 200mg/ml was selected for detection (at this temperature, all materials have a heating effect, especially photothermal), a magnetothermal photothermal platform was built, and then the photothermal and magnetic The same time is measured under thermal experimental conditions, and infrared thermal imaging is used to take pictures to record the temperature change, and then the time-temperature curve is drawn.
图6为材料的磁热光热联合曲线图。其中图6A的实验条件为500KHz,30A,发现此条件下,温度10min内上升10℃左右,而同样的浓度条件下,PTT的升温相比较而言更明显,有16℃左右,如图6B所示,而叠加后,温差有20℃左右,升温更加明显,说明MFH与PTT叠加的效果更好,也进一步表明了叠加使用的可行性与与效果。接下来我们选择200μg/mL材料进行磁热加光热的尝试,如图6D所示,发现温差更明显,温度能达到70℃以上,并且温差超过了30℃,效果非常好。最后发现两者联合使用后,温度上升更明显,上升速度更快,温度更高,证实了均为热疗的磁热及光热联合使用的可能,间接说明了这种复合材料在癌症热疗领域的有着极其优异的潜能。Figure 6 is the combined magneto-thermal-photothermal curve of the material. The experimental condition in Figure 6A is 500KHz, 30A. It is found that under this condition, the temperature rises by about 10°C within 10 minutes, and under the same concentration conditions, the temperature rise of PTT is relatively more obvious, about 16°C, as shown in Figure 6B. After superposition, the temperature difference is about 20°C, and the temperature rise is more obvious, which shows that the superposition effect of MFH and PTT is better, and further shows the feasibility and effect of superimposed use. Next, we chose 200μg/mL material to try magnetothermal plus photothermal. As shown in Figure 6D, we found that the temperature difference is more obvious, the temperature can reach more than 70°C, and the temperature difference exceeds 30°C, the effect is very good. Finally, it was found that after the combined use of the two, the temperature rise was more obvious, the rising speed was faster, and the temperature was higher, which confirmed the possibility of the combined use of magneto-thermal and photothermal, both of which are hyperthermia, and indirectly explained the role of this composite material in cancer hyperthermia. The field has great potential.
以上所述,仅为本发明较佳实施例而已,故不能依此限定本发明实施的范围,即依本发明专利范围及说明书内容所作的等效变化与修饰,皆应仍属本发明涵盖的范围内。The above is only a preferred embodiment of the present invention, so the scope of implementation of the present invention cannot be limited accordingly, that is, equivalent changes and modifications made according to the patent scope of the present invention and the content of the specification should still be covered by the present invention within range.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810482385.8A CN108578698A (en) | 2018-05-18 | 2018-05-18 | Purposes of the Prussian blue-Manganese Ferrite composite nano materials as magnetic heat/photo-thermal combination therapy agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810482385.8A CN108578698A (en) | 2018-05-18 | 2018-05-18 | Purposes of the Prussian blue-Manganese Ferrite composite nano materials as magnetic heat/photo-thermal combination therapy agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108578698A true CN108578698A (en) | 2018-09-28 |
Family
ID=63631827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810482385.8A Pending CN108578698A (en) | 2018-05-18 | 2018-05-18 | Purposes of the Prussian blue-Manganese Ferrite composite nano materials as magnetic heat/photo-thermal combination therapy agent |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108578698A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116809087A (en) * | 2023-06-28 | 2023-09-29 | 东南大学 | Photo-thermal catalyst for condensing depolymerized lignin and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102264632A (en) * | 2008-12-24 | 2011-11-30 | NURIVista株式会社 | Method for preparing engineered mg doped ferrite superparamagnetic nano particle and mg doped ferrite superparamagnetic nano particles engineered by same |
| CN104001173A (en) * | 2014-06-09 | 2014-08-27 | 上海师范大学 | A water-soluble multifunctional CoFe2O4@MnFe2O4@polypyrrole satellite structure nanomaterial and its preparation method and application |
| CN106620730A (en) * | 2017-01-24 | 2017-05-10 | 厦门大学 | Preparation method of T1/T2 bimodal nano-contrast agent |
| RU2633918C2 (en) * | 2016-04-01 | 2017-10-19 | Общество с ограниченной ответственностью "Фармаг" | Method for treatment of malignant new-formations by magnetic hyperthermia and pharmaceutical compositions for application in indicated method |
-
2018
- 2018-05-18 CN CN201810482385.8A patent/CN108578698A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102264632A (en) * | 2008-12-24 | 2011-11-30 | NURIVista株式会社 | Method for preparing engineered mg doped ferrite superparamagnetic nano particle and mg doped ferrite superparamagnetic nano particles engineered by same |
| CN104001173A (en) * | 2014-06-09 | 2014-08-27 | 上海师范大学 | A water-soluble multifunctional CoFe2O4@MnFe2O4@polypyrrole satellite structure nanomaterial and its preparation method and application |
| RU2633918C2 (en) * | 2016-04-01 | 2017-10-19 | Общество с ограниченной ответственностью "Фармаг" | Method for treatment of malignant new-formations by magnetic hyperthermia and pharmaceutical compositions for application in indicated method |
| CN106620730A (en) * | 2017-01-24 | 2017-05-10 | 厦门大学 | Preparation method of T1/T2 bimodal nano-contrast agent |
Non-Patent Citations (2)
| Title |
|---|
| AGNIESZKA SZPAK等: "T1-T2 dual-modal MRI contrast agents based on superparamagnetic iron oxide nanoparticles with surface attached gadolinium complexes", 《J. NANOPART. RES.》 * |
| 金星 等: "纳米普鲁士蓝在肿瘤成像与治疗中的功能开发", 《生物医学工程学杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116809087A (en) * | 2023-06-28 | 2023-09-29 | 东南大学 | Photo-thermal catalyst for condensing depolymerized lignin and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Bacteria‐mediated tumor therapy via photothermally‐programmed cytolysin a expression | |
| Tao et al. | Surface plasmon resonance–enhanced photoacoustic imaging and photothermal therapy of endogenous H2S‐triggered Au@ Cu2O | |
| CN107661512B (en) | A kind of MnO2Wrap up the nano particle and preparation method and application of poly-dopamine | |
| CN105412927B (en) | A kind of preparation method of the additive Mn hollow structure prussian blue nano particle with high light thermal property | |
| CN109718197B (en) | A kind of magnetic injectable hydrogel, preparation method and application | |
| Zhang et al. | New Xanthene Dyes with NIR‐II Emission Beyond 1200 nm for Efficient Tumor Angiography and Photothermal Therapy | |
| Ma et al. | Simultaneous activation of short‐wave infrared (SWIR) light and paramagnetism by a functionalized shell for high penetration and spatial resolution theranostics | |
| CN116477668B (en) | Two-dimensional ferric sulfide nano-sheet and preparation method and application thereof | |
| CN104162173B (en) | A kind of preparation method and applications of fluorescence MRI bimodal image probe | |
| CN105999309A (en) | Protein biological template-based gadolinium-doped copper sulfide nano-particles and preparation method thereof | |
| Zhang et al. | Microwave-assisted ultrafast fabrication of high-performance polypyrrole nanoparticles for photothermal therapy of tumors in vivo | |
| CN110237275A (en) | A kind of nano-diagnostic agent and preparation method and application thereof | |
| CN117482231A (en) | A porous copper-manganese bimetallic nanomaterial used in tumor immunotherapy and its preparation method | |
| Sun et al. | Polydopamine-functionalized selenium nanoparticles as an efficient photoresponsive antibacterial platform | |
| CN113304280A (en) | Rare earth up-conversion composite nano material for treating tumor | |
| Wang et al. | Urchin-like tungsten suboxide for photoacoustic imaging-guided photothermal and photodynamic cancer combination therapy | |
| Zhao et al. | A cyanine with 83.2% photothermal conversion efficiency and absorption wavelengths over 1200 nm for photothermal therapy | |
| Zhao et al. | Thiophene engineering of near-infrared D-π-A nano-photosensitizers for enhanced multiple phototheranostics and inhibition of tumor metastasis | |
| CN108578698A (en) | Purposes of the Prussian blue-Manganese Ferrite composite nano materials as magnetic heat/photo-thermal combination therapy agent | |
| Chelora et al. | Single molecular nanomedicine with NIR light-initiated superoxide radical, singlet oxygen and thermal generation for hypoxia-overcoming cancer therapy | |
| CN108187048A (en) | A kind of photo-thermal-optoacoustic-magnetic resonance diagnosis and treatment reagent and preparation method thereof | |
| CN111228489A (en) | A kind of ferric oxide bismuth sulfide nanocomposite material and its preparation and application | |
| CN107098387A (en) | A kind of aqueous phase preparation method of near-infrared photo-thermal nano material bismuth sulfide | |
| Fan et al. | Acceptor–donor–acceptor-type molecules with large electrostatic potential difference for effective NIR photothermal therapy | |
| CN108524954A (en) | A kind of preparation method having photo-thermal and the tungsten oxide crystal composite material at image effect |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180928 |
|
| RJ01 | Rejection of invention patent application after publication |